Actinium Pharmaceuticals Inc (AMEX:ATNM) price on current trading day, rose 9.93% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.33.
A look at the stock’s price movement, the level at last check in today’s session was $1.21, moving within a range at $1.27 and $1.49. The beta value (5-Year monthly) was 0.108. Turning to its 52-week performance, $10.24 and $1.03 were the 52-week high and 52-week low respectively. Overall, ATNM moved 13.68% over the past month.
Actinium Pharmaceuticals Inc’s market cap currently stands at around $41.50 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-13.
The average forecast suggests down to a -100.00% growth in sales growth compared to quarterly growth in the same period last fiscal year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATNM is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend ATNM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ATNM’s current price about 14.07% and 10.57% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 61.38, while 7-day volatility ratio is 6.15% and 6.16% in the 30-day chart. Further, Actinium Pharmaceuticals Inc (ATNM) has a beta value of -0.09, and an average true range (ATR) of 0.09. Analysts have given the company’s stock an average 52-week price target of $4.95, forecast between a low of $4 and high of $24.26. Looking at the price targets, the low is -200.75% off recent price level in today’s trading while to achieve the yearly target high, it has to move -1724.06%. Nonetheless, investors will most likely welcome a -272.18% jump to $4.95 which is the analysts’ median price.
If we refocus on Actinium Pharmaceuticals Inc (AMEX:ATNM), historical trading data shows that trading volumes averaged 0.15 over the past 10 days and 216.29K over the past 3 months. The company’s latest data on shares outstanding shows there are 31.20 million shares.
The 2.54% of Actinium Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 28.73% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.25 million on 2025-02-28, giving us a short ratio of 13.64. The data shows that as of 2025-02-28 short interest in Actinium Pharmaceuticals Inc (ATNM) stood at 719.9999999999999 of shares outstanding, with shares short rising to 2.02 million registered in 2025-01-31. Current price change has pushed the stock 5.56% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATNM stock continues to rise going into the next quarter.
